Literature DB >> 8050249

The Hannover experience in management of pelvic fractures.

T Pohlemann1, U Bosch, A Gänsslen, H Tscherne.   

Abstract

Between 1972 and 1993, 1899 patients with fractures of the pelvis were treated at the authors institution. The pelvic ring was fractured in 1479 patients, and 1029 sustained polytrauma. A retrospective study included four parts: (1) Demographic analysis of 1409 patients showed an increase in the severity of pelvic and general trauma during this period. The 17.7% mortality rate was predicted by the Hannover Polytrauma Score and associated extrapelvic blunt trauma. (2) Residual displacement after operative treatment of the pelvis was analyzed in 221 patients. In C type (Tile) fractures residual displacement correlated with external fixation and solely anterior stabilization. (3) Outcome after operative treatment was analyzed in a consecutive series of 58 patients an average of 2.2 years after trauma. Pelvic pain was frequent (Type B 11%, Type C 66%) and correlated with posterior displacement over 5 mm and primary neurological injuries. (4) Mortality after complex pelvic trauma (pelvic fracture with soft tissue injury) decreased from 48.1% to 29.6% during these years. Standardized protocols for primary care and operative procedures of pelvic injuries optimize therapy. Complex pelvic trauma requires early, aggressive surgical management with surgical hemostasis. Further developments in open reduction and internal fixation of the pelvis focus on minimizing additional soft tissue trauma and implants.

Entities:  

Mesh:

Year:  1994        PMID: 8050249

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  41 in total

1.  [Application of the pelvic C-clamp].

Authors:  T Pohlemann; U Culemann; G Tosounidis; A Kristen
Journal:  Unfallchirurg       Date:  2004-12       Impact factor: 1.000

2.  Diagnostic value of pelvic radiography in the initial trauma series in blunt trauma.

Authors:  Micael E A Their; Frank V Bensch; Seppo K Koskinen; Lauri Handolin; Martti J Kiuru
Journal:  Eur Radiol       Date:  2005-01-19       Impact factor: 5.315

Review 3.  Emergent management of pelvic ring injuries: an update.

Authors:  Khitish Mohanty; Damian Musso; James N Powell; John B Kortbeek; Andrew W Kirkpatrick
Journal:  Can J Surg       Date:  2005-02       Impact factor: 2.089

4.  Surgical considerations with the operative fixation of unstable paediatric pelvic ring injuries.

Authors:  Mohamed Kenawey
Journal:  Int Orthop       Date:  2017-04-13       Impact factor: 3.075

Review 5.  Treatment and outcomes of pelvic malunions and nonunions: a systematic review.

Authors:  Nikolaos K Kanakaris; Antonios G Angoules; Vassilios S Nikolaou; George Kontakis; Peter V Giannoudis
Journal:  Clin Orthop Relat Res       Date:  2009-01-30       Impact factor: 4.176

Review 6.  Pelvic ring disruptions: treatment modalities and analysis of outcomes.

Authors:  C Papakostidis; N K Kanakaris; G Kontakis; P V Giannoudis
Journal:  Int Orthop       Date:  2008-05-07       Impact factor: 3.075

7.  [The pelvic subcutaneous cross-over internal fixator].

Authors:  M Kuttner; A Klaiber; T Lorenz; B Füchtmeier; R Neugebauer
Journal:  Unfallchirurg       Date:  2009-07       Impact factor: 1.000

Review 8.  How should we manage exsanguinating pelvic fractures in the United Kingdom?

Authors:  S Meek; R Ross
Journal:  J Accid Emerg Med       Date:  1998-01

Review 9.  Preperitoneal pelvic packing for exsanguinating pelvic fractures.

Authors:  Clay Cothren Burlew
Journal:  Int Orthop       Date:  2017-04-26       Impact factor: 3.075

10.  Acute management of hemodynamically unstable pelvic trauma patients: time for a change? Multicenter review of recent practice.

Authors:  Diederik O Verbeek; Diederik Verbeek; Michael Sugrue; Zsolt Balogh; Danny Cass; Ian Civil; Ian Harris; Thomas Kossmann; Steve Leibman; Valerie Malka; Anthony Pohl; Sudhakar Rao; Martin Richardson; Michael Schuetz; Caesar Ursic; Vanessa Wills
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.